Here are five points:
1. Zacks has a $37 price objective on Smith & Nephew’s stock.
2. Smith & Nephew has a one-year low of $30.23 and a one-year high of $37.84.
3. The company’s 50-day moving average is $33.07 and the 200-day moving average is $34.51.
4. Smith & Nephew has a market cap of $13.93 billion.
5. The P/E ratio is 34.18.
More articles on devices:
ConforMIS reports Q4, full year results — 12 things to know
Hip, knee orthopedic surgical implants market to reach $33M by 2022: 3 takeaways
FDA releases new draft guidance for orthopedic device developers — 6 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
